[1]
Condoluci, A., Théaudin, M., Schwotzer, R., Pazhenkottil, A.P., Arosio, P., Averaimo, M., Bacher, U., Bode, P., Cavalli, A., Dirnhofer, S., Djerbi, N., Dobner, S., Fehr, T., Garofalo, M., Gaspert, A., Gerull, S., Heimgartner, R., Hübers, A., Jung, H.H., Kessler, C., Knöpfel, R., Laptseva, N., Magini, G., Manka, R., Mazzucchelli, L., Meyer, M., Mihaylova, V., Monney, P., Mylonas, A., Nkoulou, R., Pabst, T., Pfister, O., Rüfer, A., Schmidt, A., Seeger, H., Stämpfli, S.F., Stirnimann, G., Suter, T., Treglia, G., Tzankov, A., Vetter, F., Zweier, M., Flammer, A.J. and Gerber, B. 2021. Management of transthyretin amyloidosis: Guidelines from the 1st Swiss Amyloidosis Network (SAN) Consensus conference. Swiss Medical Weekly. 151, 4142 (Oct. 2021), w30053. DOI:https://doi.org/10.4414/SMW.2021.w30053.